Regulation of cancer stem cell properties, angiogenesis, and vasculogenic mimicry by miR-450a-5p/SOX2 axis in colorectal cancer.

Cell Death & Disease
Jiaxuan ChenHaoxuan Zheng

Abstract

Growing evidence indicates that a small number of cancer cells express stem cell markers and possess stem cell-like properties that promote malignant progression. Sex-determining region Y-box2 (SOX2) is a stem cell transcription factor essential for maintaining the properties of cancer stem cell (CSC). As CSC properties have been associated with angiogenesis and vasculogenic mimicry (VM), we aimed to comprehensively investigate whether SOX2 regulates CSC properties, angiogenesis, and VM in colorectal carcinoma (CRC) and its potential mechanism in this study. For this study, sphere formation assay, flow cytometry, cell survival analysis, tube formation, 3D culture, immunoblot, mouse model, and luciferase reporter assay were performed in vivo and in vitro. Expressions of SOX2 and miR-450a-5p in CRC tissue samples were examined through immunohistochemistry. First, the expression of SOX2 was not only associated with poor differentiation and prognosis but also promoted angiogenesis and VM. Knockdown of SOX2 ceased stemness properties, angiogenesis, and VM, along with decreased expression of CD133, CD31, and VE-cadherin as observed in functional experiments. Downregulation of SOX2 was found to inhibit tumorigenesis in vivo. Second, m...Continue Reading

References

Oct 7, 2004·Journal of the National Cancer Institute·Daisy W J van der SchaftMary J C Hendrix
Nov 19, 2004·Nature·Sheila K SinghPeter B Dirks
Feb 20, 2007·Cancer Letters·Shiwu ZhangBaocun Sun
Jun 6, 2007·Proceedings of the National Academy of Sciences of the United States of America·Piero DalerbaMichael F Clarke
Sep 21, 2007·Nature Reviews. Cancer·Richard J Gilbertson, Jeremy N Rich
Apr 1, 2008·Cancer Biology & Therapy·Jun-Yan WangBao-Cun Sun
Jun 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christine E Eyler, Jeremy N Rich
Jan 14, 2011·The Journal of Surgical Research·Junko MatsuokaKosei Hirakawa
Mar 6, 2012·Cancer Letters·Domenico Ribatti
Sep 15, 2012·Experimental and Therapeutic Medicine·Zhihong WengLibo Chen
Jul 23, 2013·Cancer Research·Petra M BareissClaudia Lengerke
Nov 2, 2013·Oncology Letters·Yun-Long FanXin-Hua Liang
Mar 7, 2014·The Journal of Biological Chemistry·Andrew T HaleAnne Hamik
Mar 25, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yan-Xia LuXue-Nong Li
Oct 30, 2014·International Journal of Molecular Sciences·Tieju LiuFang Liu
Dec 1, 2015·Archives of Pathology & Laboratory Medicine·Jesús R GarciaPatricia Chévez-Barrios
Mar 11, 2016·Journal of Cancer Research and Clinical Oncology·Yansu ChenJianwei Zhou
May 26, 2017·Molecular Carcinogenesis·Jiaxuan ChenHaoxuan Zheng
Jul 14, 2018·Journal of Experimental & Clinical Cancer Research : CR·Juan LuXiang-Ping Li

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
Assay

Software Mentioned

microRNA
Venny
TargetScan
miRWalk

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.